US 10888578
Exon skipping oligomer conjugates for muscular dystrophy
granted A61KA61K31/712A61K31/7125
Quick answer
US patent 10888578 (Exon skipping oligomer conjugates for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/712, A61K31/7125, A61K47/645, A61P